Free Trial

Stonehage Fleming Financial Services Holdings Ltd Has $2.84 Million Position in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Stonehage Fleming Financial Services Holdings Ltd significantly reduced its holdings in UnitedHealth Group by 96.4%, now owning only 9,110 shares valued at approximately $2.84 million.
  • Analyst ratings for UnitedHealth Group show a mixed outlook, with a consensus rating of "Hold" and an average price target of $383.09.
  • UnitedHealth Group recently reported quarterly earnings of $4.08 EPS, missing the consensus estimate, while its revenue increased by 12.9% year-over-year.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Stonehage Fleming Financial Services Holdings Ltd reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 96.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,110 shares of the healthcare conglomerate's stock after selling 243,295 shares during the quarter. Stonehage Fleming Financial Services Holdings Ltd's holdings in UnitedHealth Group were worth $2,842,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Citizens National Bank Trust Department grew its position in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Caitlin John LLC grew its position in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management bought a new position in UnitedHealth Group during the second quarter worth about $1,324,000. Wealth Effects LLC lifted its stake in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock worth $1,463,000 after purchasing an additional 591 shares during the period. Finally, Arlington Partners LLC bought a new position in UnitedHealth Group during the second quarter worth about $2,229,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have commented on UNH shares. Weiss Ratings restated a "sell (d+)" rating on shares of UnitedHealth Group in a research note on Wednesday. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Barclays lifted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a research note on Thursday. Finally, Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an "outperform" rating in a research note on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $383.09.

Get Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UNH stock opened at $354.30 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50 day moving average price of $318.21 and a 200 day moving average price of $349.25. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market capitalization of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Buy the Dip: 3 Healthcare Stocks Ready to Recover
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines